Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDATobacco: Do you know these tobacco facts? ✔️ Cigarette smoking can harm nearly every organ in your body. ✔️ Teens who smo… https://t.co/Z0xGqupEK4

RT @CBP_McAleenan: To the CBP workforce: Thank you. We are working to ensure you paid as quickly as possible. https://t.co/oe6BW2T2q2

RT @ASCO: Don’t miss: Exclusive interview w FDA Commissioner @SGottliebFDA by our CEO @CliffordHudis on the next ASCO in Action #podcast, coming January 29 https://t.co/5Sn1DgR3ca

My message to my #FDA colleagues today. I admire your continued dedication and the fortitude of your families through these challenging times. We’re finalizing plans to ensure all of our esteemed staff receive back pay as quickly as possible, and by Thursday, January 31st. https://t.co/D2GcukNWuZ

THREAD: Some information for my colleagues - For assistance with questions related to benefits, pay, IT issues, badging and other shutdown related matters; there will be welcome back tables located in the building 32 Cafeteria. 1/4

For those with PIV badges that recently expired, these badges were extended through Feb 1st. Please contact the FDA Badging Office at 301-796-4000 as soon as possible to schedule an appointment to renew expired badges. We look forward to seeing all our colleagues tomorrow! 4/4

There will also be IT kiosks located across the campus to provide assistant with IT issues. These kiosks will be stationed in building 2 (on the 3rd Floor), building 32 (in the cafeteria), building 51 (in the atrium) and building 66 (in the atrium). 2/4

A mobile device reset station is also available in the building 71/75 atrium outside of rooms 1535/1540. If you have an issue logging into your mobile device, please see the technicians there for assistance. 3/4

RT @SGottliebFDA: THREAD: Some information for my colleagues - For assistance with questions related to benefits, pay, IT issues, bad… https://t.co/ne0T0idEEd

RT @StephCaccomo: Me going back to work @US_FDA after #shutdown. So happy to be back at work and proud of all those who kept working… https://t.co/UeNy6JUpC3

I look forward to being outside Building 1 today to greet ALL my colleagues as we return to our posts TOGETHER. I know there will be additional challenges ahead as we catch up on missed work and deadlines. I’ll support you in all of these efforts as we forge ahead as ONE #FDA https://t.co/0zJSmNXU9o

RT @FDAJobs: Happy Monday morning! Be sure to use “FDA” as a keyword when searching for jobs on https://t.co/89Kf9EjzUB. Have a… https://t.co/mSZuS5Fpww

RT @StephCaccomo: It’s great to be back! https://t.co/39fioyDEaT

RT @SGottliebFDA: I look forward to being outside Building 1 today to greet ALL my colleagues as we return to our posts TOGETHER. I k… https://t.co/LwsPK722WJ

#FDA will update soon on application backlogs related to shutdown and the efficient process we'll use to work through these priorities. Rough #’s: Normally we'd have gotten about 400 generic apps in Dec/Jan. For January we'd have received about 300 510Ks and a dozen novel NDAs.

@Carolynyjohnson Most sponsors were holding their applications during the shutdown so those applications will all come in now. Sponsors knew we couldn’t take new submissions, so few tried to submit applications during the funding lapse.

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, and Jeff Shuren, M.D., Director of the Center for Devices and Radiol… https://t.co/xxDZVC2u23

We’re announcing today that we plan to hold a public meeting of our General and Plastic Surgery Devices Panel on March 25-26 at #FDA headquarters to discuss a range of topics concerning the benefit-risk profile of breast implants. https://t.co/uTOUzi1Rmv

This meeting seeks public input on benefit/risk considerations and possible measures to further address certain risks with breast implants to help ensure the public continues to have accurate, scientifically-sound information about the benefits and risks of breast implants.

We encourage members of the public to provide comments to the panel and FDA on this topic. We plan to post more information and an agenda 15 days in advance of the meeting. More info about our work on breast implant safety is available here: https://t.co/uTOUzi1Rmv

RT @FDATobacco: Do you know these tobacco facts? ✔️ Cigarette smoking can harm nearly every organ in your body. ✔️ Teens who smo… https://t.co/Z0xGqupEK4

RT @CBP_McAleenan: To the CBP workforce: Thank you. We are working to ensure you paid as quickly as possible. https://t.co/oe6BW2T2q2

RT @ASCO: Don’t miss: Exclusive interview w FDA Commissioner @SGottliebFDA by our CEO @CliffordHudis on the next ASCO in Action #podcast, coming January 29 https://t.co/5Sn1DgR3ca

My message to my #FDA colleagues today. I admire your continued dedication and the fortitude of your families through these challenging times. We’re finalizing plans to ensure all of our esteemed staff receive back pay as quickly as possible, and by Thursday, January 31st. https://t.co/D2GcukNWuZ

THREAD: Some information for my colleagues - For assistance with questions related to benefits, pay, IT issues, badging and other shutdown related matters; there will be welcome back tables located in the building 32 Cafeteria. 1/4

For those with PIV badges that recently expired, these badges were extended through Feb 1st. Please contact the FDA Badging Office at 301-796-4000 as soon as possible to schedule an appointment to renew expired badges. We look forward to seeing all our colleagues tomorrow! 4/4

There will also be IT kiosks located across the campus to provide assistant with IT issues. These kiosks will be stationed in building 2 (on the 3rd Floor), building 32 (in the cafeteria), building 51 (in the atrium) and building 66 (in the atrium). 2/4

A mobile device reset station is also available in the building 71/75 atrium outside of rooms 1535/1540. If you have an issue logging into your mobile device, please see the technicians there for assistance. 3/4

RT @SGottliebFDA: THREAD: Some information for my colleagues - For assistance with questions related to benefits, pay, IT issues, bad… https://t.co/ne0T0idEEd

RT @StephCaccomo: Me going back to work @US_FDA after #shutdown. So happy to be back at work and proud of all those who kept working… https://t.co/UeNy6JUpC3

I look forward to being outside Building 1 today to greet ALL my colleagues as we return to our posts TOGETHER. I know there will be additional challenges ahead as we catch up on missed work and deadlines. I’ll support you in all of these efforts as we forge ahead as ONE #FDA https://t.co/0zJSmNXU9o

RT @FDAJobs: Happy Monday morning! Be sure to use “FDA” as a keyword when searching for jobs on https://t.co/89Kf9EjzUB. Have a… https://t.co/mSZuS5Fpww

RT @StephCaccomo: It’s great to be back! https://t.co/39fioyDEaT

RT @SGottliebFDA: I look forward to being outside Building 1 today to greet ALL my colleagues as we return to our posts TOGETHER. I k… https://t.co/LwsPK722WJ

#FDA will update soon on application backlogs related to shutdown and the efficient process we'll use to work through these priorities. Rough #’s: Normally we'd have gotten about 400 generic apps in Dec/Jan. For January we'd have received about 300 510Ks and a dozen novel NDAs.

@Carolynyjohnson Most sponsors were holding their applications during the shutdown so those applications will all come in now. Sponsors knew we couldn’t take new submissions, so few tried to submit applications during the funding lapse.

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, and Jeff Shuren, M.D., Director of the Center for Devices and Radiol… https://t.co/xxDZVC2u23

We’re announcing today that we plan to hold a public meeting of our General and Plastic Surgery Devices Panel on March 25-26 at #FDA headquarters to discuss a range of topics concerning the benefit-risk profile of breast implants. https://t.co/uTOUzi1Rmv

This meeting seeks public input on benefit/risk considerations and possible measures to further address certain risks with breast implants to help ensure the public continues to have accurate, scientifically-sound information about the benefits and risks of breast implants.

We encourage members of the public to provide comments to the panel and FDA on this topic. We plan to post more information and an agenda 15 days in advance of the meeting. More info about our work on breast implant safety is available here: https://t.co/uTOUzi1Rmv